Cargando…

Mobilization of the bla(KPC-14) gene among heterogenous plasmids in extensively drug-resistant hypervirulent Klebsiella pneumoniae

INTRODUCTION: Ceftazidime/avibactam (CZA) is an effective alternative for the treatment of infections caused by KPC-producing carbapenem-resistant Klebsiella pneumoniae (CRKP). However, KPC variants with CZA resistance have been observed in clinical isolates, further limiting the treatment options o...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Lin, Shen, Weiyi, Cai, Jiachang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684954/
https://www.ncbi.nlm.nih.gov/pubmed/38033558
http://dx.doi.org/10.3389/fmicb.2023.1261261
_version_ 1785151521736884224
author Wang, Lin
Shen, Weiyi
Cai, Jiachang
author_facet Wang, Lin
Shen, Weiyi
Cai, Jiachang
author_sort Wang, Lin
collection PubMed
description INTRODUCTION: Ceftazidime/avibactam (CZA) is an effective alternative for the treatment of infections caused by KPC-producing carbapenem-resistant Klebsiella pneumoniae (CRKP). However, KPC variants with CZA resistance have been observed in clinical isolates, further limiting the treatment options of clinical use. METHODS: In this study, we isolated three KPC-14-producing CRKP from two patients in intensive care units without CZA therapy. The antimicrobial susceptibility was determined using the broth microdilution method. Three CRKP were subjected to whole-genome sequencing to analyze the phylogenetic relatedness and the carriage of antimicrobial resistance genes and virulence factors. Long-read sequencing was also performed to obtain the complete sequences of the plasmids. The horizontal transfer of the bla(KPC-14) gene was evaluated by conjugation experiments. RESULTS: Three CRKP displayed resistance or reduced susceptibility to ceftazidime/avibactam, colistin, and tigecycline. Single-nucleotide polymorphism (SNP) analysis demonstrated the close phylogenetic distance between these strains. A highly similar IncFII/IncR plasmid encoding bla(KPC-14) was shared by three CRKP, with bla(KPC-14) located in an NTE(KPC)-Ib element with the core region of ISKpn27- bla(KPC-14)-ISKpn6. This structure containing bla(KPC-14) was also observed in another tet(A)-carrying plasmid that belonged to an unknown Inc-type in two out of three isolates. The horizontal transferability of these integrated plasmids to Escherichia coli EC600 was confirmed by the cotransmission of tet(A) and bla(KPC-14) genes, but the single transfer of bla(KPC-14) on the IncFII/IncR plasmid failed. Three CRKP expressed yersiniabactin and carried a hypervirulence plasmid encoding rmpA2 and aerobactin-related genes, and were thus classified as carbapenem-resistant hypervirulent K. pneumoniae (hvKP). DISCUSSION: In this study, we reported the evolution of a mosaic plasmid encoding the bla(KPC-14) gene via mobile elements in extensively drug-resistant hvKP. The bla(KPC-14) gene is prone to integrate into other conjugative plasmids via the NTE(KPC)-Ib element, further facilitating the spread of ceftazidime/avibactam resistance.
format Online
Article
Text
id pubmed-10684954
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-106849542023-11-30 Mobilization of the bla(KPC-14) gene among heterogenous plasmids in extensively drug-resistant hypervirulent Klebsiella pneumoniae Wang, Lin Shen, Weiyi Cai, Jiachang Front Microbiol Microbiology INTRODUCTION: Ceftazidime/avibactam (CZA) is an effective alternative for the treatment of infections caused by KPC-producing carbapenem-resistant Klebsiella pneumoniae (CRKP). However, KPC variants with CZA resistance have been observed in clinical isolates, further limiting the treatment options of clinical use. METHODS: In this study, we isolated three KPC-14-producing CRKP from two patients in intensive care units without CZA therapy. The antimicrobial susceptibility was determined using the broth microdilution method. Three CRKP were subjected to whole-genome sequencing to analyze the phylogenetic relatedness and the carriage of antimicrobial resistance genes and virulence factors. Long-read sequencing was also performed to obtain the complete sequences of the plasmids. The horizontal transfer of the bla(KPC-14) gene was evaluated by conjugation experiments. RESULTS: Three CRKP displayed resistance or reduced susceptibility to ceftazidime/avibactam, colistin, and tigecycline. Single-nucleotide polymorphism (SNP) analysis demonstrated the close phylogenetic distance between these strains. A highly similar IncFII/IncR plasmid encoding bla(KPC-14) was shared by three CRKP, with bla(KPC-14) located in an NTE(KPC)-Ib element with the core region of ISKpn27- bla(KPC-14)-ISKpn6. This structure containing bla(KPC-14) was also observed in another tet(A)-carrying plasmid that belonged to an unknown Inc-type in two out of three isolates. The horizontal transferability of these integrated plasmids to Escherichia coli EC600 was confirmed by the cotransmission of tet(A) and bla(KPC-14) genes, but the single transfer of bla(KPC-14) on the IncFII/IncR plasmid failed. Three CRKP expressed yersiniabactin and carried a hypervirulence plasmid encoding rmpA2 and aerobactin-related genes, and were thus classified as carbapenem-resistant hypervirulent K. pneumoniae (hvKP). DISCUSSION: In this study, we reported the evolution of a mosaic plasmid encoding the bla(KPC-14) gene via mobile elements in extensively drug-resistant hvKP. The bla(KPC-14) gene is prone to integrate into other conjugative plasmids via the NTE(KPC)-Ib element, further facilitating the spread of ceftazidime/avibactam resistance. Frontiers Media S.A. 2023-11-15 /pmc/articles/PMC10684954/ /pubmed/38033558 http://dx.doi.org/10.3389/fmicb.2023.1261261 Text en Copyright © 2023 Wang, Shen and Cai. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Wang, Lin
Shen, Weiyi
Cai, Jiachang
Mobilization of the bla(KPC-14) gene among heterogenous plasmids in extensively drug-resistant hypervirulent Klebsiella pneumoniae
title Mobilization of the bla(KPC-14) gene among heterogenous plasmids in extensively drug-resistant hypervirulent Klebsiella pneumoniae
title_full Mobilization of the bla(KPC-14) gene among heterogenous plasmids in extensively drug-resistant hypervirulent Klebsiella pneumoniae
title_fullStr Mobilization of the bla(KPC-14) gene among heterogenous plasmids in extensively drug-resistant hypervirulent Klebsiella pneumoniae
title_full_unstemmed Mobilization of the bla(KPC-14) gene among heterogenous plasmids in extensively drug-resistant hypervirulent Klebsiella pneumoniae
title_short Mobilization of the bla(KPC-14) gene among heterogenous plasmids in extensively drug-resistant hypervirulent Klebsiella pneumoniae
title_sort mobilization of the bla(kpc-14) gene among heterogenous plasmids in extensively drug-resistant hypervirulent klebsiella pneumoniae
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684954/
https://www.ncbi.nlm.nih.gov/pubmed/38033558
http://dx.doi.org/10.3389/fmicb.2023.1261261
work_keys_str_mv AT wanglin mobilizationoftheblakpc14geneamongheterogenousplasmidsinextensivelydrugresistanthypervirulentklebsiellapneumoniae
AT shenweiyi mobilizationoftheblakpc14geneamongheterogenousplasmidsinextensivelydrugresistanthypervirulentklebsiellapneumoniae
AT caijiachang mobilizationoftheblakpc14geneamongheterogenousplasmidsinextensivelydrugresistanthypervirulentklebsiellapneumoniae